Implication of expression of osteopontin and its receptor integrin ανβ3 in the placenta in the development of preeclampsia

Abstract

To investigate the expression of osteopontin (OPN) and its receptor integrin ανβ3 in the placental tissue from pregnant women complicated with preeclampsia, the expression of OPN and ανβ3 in the placenta of the pregnant women with preeclampsia and healthy pregnant women was detected by immunohistochemistry, Western blotting and RT-PCR. Our results showed that OPN and ανβ3 protein were expressed in the placenta from normal pregnant woman and those with preeclampsia. OPN was located in the placental syncytiotrophoblasts and the cytoplasm of capillary endothelial cells and integrin ανβ3 was mainly expressed on the surface of trophoblast cells. Expression of OPN and integrin ανβ3 in the placental tissue from preeclampsia subjects was significantly lower than that from the control group (P<0.05). Compared with the control group, expression of OPN in the placental tissue from preeclampsia group was significantly lower (P<0.05) but there was no significant difference in the expression of αν and β3 between the preeclampsia group and the controls. It is concluded that OPN and its receptor integrin ανβ3 may be involved in the pathogenesis of preeclampsia.

Keywords

osteopontin / integrin ανβ3 / placenta / preeclampsia

References

[1] RedmanC.W., SargentI.L.. Latest advances in underst-anding preeclampsia. Science, 2005, 308(5728): 1592-1594

[2] SibaiB., DekkerG., KupfermincM.. Pre-eclampsia. Lancet, 2005, 365(9461): 785-799

[3] WangY., ChenB., ShenD., XueS.. Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning. Heart Vessels, 2009, 24(2): 116-123

[4] ShuiH.A., KaS.M., YangS.M., et al.. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis. Transl Res, 2007, 150(4): 216-222

[5] JohnsonG.A., BurghardtR.C., JoyceM.M., et al.. Osteopontin expression in uterine stroma indicates a decidualization-like differentiation during ovine pregnancy. Biol Reprod, 2003, 68(6): 1951-1958

[6] ApparaoK.B., IlleraM.J., BeylerS.A., et al.. Regulated expression of osteopontin in the peri-implantation rabbit uterus. Biol Reprod, 2003, 68(5): 1484-1490

[7] DenhardtD.T., NodaM., O’ReganA.W., et al.. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest, 2001, 107(9): 1055-1061

[8] JohnsonG.A., BurghardtR.C., BazerF.W., et al.. Osteopontin: roles in implantation and placentation. Biol Reprod, 2003, 69(5): 1458-1471

[9] BrieseJ., OberndorferM., PatschenikC., et al.. Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells. J Clin Endocrinol Metab, 2005, 90(9): 5407-5413

[10] JohnsonG.A., BurghardtR.C., JoyceM.M., et al.. Osteopontin is synthesized by uterine glands and a 45-kDa cleavage fragment is localized at the uterine-placental interface throughout ovine pregnence. Biol Reprod, 2003, 69(1): 92-98

[11] LEJie.Gynecology and obstetrics, 20046th edBeijing, People’s Medical Publishing House: 97-106

[12] ChakrabortyC., GleesonL.M., McKinnonT., et al.. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol, 2002, 80(2): 116-124

[13] PrefumoF., SebireN.J., ThilaganathanB.. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod, 2004, 19(1): 206-209

[14] MoonK.C., ParkJ.S., NorwitzE.R., et al.. Expression of extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinase in the invasive trophoblasts at the human placental bed. Placenta, 2008, 29(5): 391-395

[15] MatthiesenL., BergG., ErnerudhJ., et al.. Immunology of preeclampsia. Chem Immunol Allergy, 2005, 89: 49-61

[16] WinnV.D., GormleyM., PaquetA.C., et al.. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology, 2009, 150(1): 452-462

[17] FranchiA., ZaretJ., ZhangX., et al.. Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. Mol Hum Reprod, 2008, 14(7): 413-421

[18] RobertsJ.M., HubelC.A.. Oxidative stress in preeclampsia. Am J Obstet Gynecol, 2004, 190(5): 1177-1178

[19] RobillardP.Y., ChaouatG., Le BouteillerP., et al.. Current debates on immunology of preeclampsia. Report of the sixth international workshop of Reunion Island (Indian Ocean, December 2008). Gynecol Obstet Fertil, 2009, 37(6): 570-578

[20] MoreauP., ContuL., AlbaF., et al.. HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage. Biol Reprod, 2008, 79(3): 459-467

[21] WardK.. Searching for genetic factors underlying pre-eclampsia: recent progress and persistent challenges. Minerva Ginecol, 2008, 60(5): 399-419

[22] ZhangZ., JiaL.T., ZhangL.L.. Polymorphism of HLA-A and HLA-B in pre-eclampsia. Beijing Da Xue Xue Bao (Chinese), 2009, 41(4): 418-425

[23] BdolahY., KarumanchiS.A., SachsB.P.. Recent advances in understanding of preeclampsia. Croat Med J, 2005, 46(5): 728-736

[24] RobertsJ.M., GammillH.S.. Preeclampsia: Recent insights. Hypertension, 2005, 46(6): 1243-1249

[25] LiuQ., HeJ., DongM. Y., et al.. Significance of increased level of serum macrophage colony-stimulating factor in patients with preeclampsia. J Zhejiang Unive [Med Sci], 2005, 34(6): 492-494

[26] O’ReganA.W., NauG.J., ChuppG.L., et al.. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today, 2000, 21(10): 475-478

[27] AshkarS., WeberG.F., Vassiliki PanoutsakopoulouV., et al.. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science, 2000, 287(5454): 860-864

[28] PhilipS., BulbuleA., KunduG.C.. Matrix metallop-roteinase-2: Mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj J, 2004, 21(8–9): 429-441

[29] RaffettoJ.D., KhalilR.A.. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol, 2008, 75(2): 345-359

[30] LockwoodC.J., OnerC., UzY.H., et al.. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod, 2008, 78(6): 1064-1072

[31] WangY.L.. Abnormal Implantation and Pathogenesis of Pre-eclampsi. J, Med Mol Biol, 2006, 3(2): 85-89